The biotechnology sector is growing and new companies have excellent opportunities to establish themselves on the market. Dr. Michael Steinwand explains what companies have to beware.
https://www.gesundheitsindustrie-bw.de/en/article/news/innovendia-keeping-the-focus-on-client-requirements/Almost 15 percent of an estimated seven million diabetes mellitus patients in Germany suffer from diabetic foot syndrome DFS. It is associated with damage to the foot nerves and blood vessels as well as the presence of chronic wounds which in thousands of cases every year precede lower leg amputations. The Konstanz-based company MTS Medical has developed a shock wave therapy system that has the potential to considerably reduce the number of amputations in the foreseeable future.
https://www.gesundheitsindustrie-bw.de/en/article/news/mts-shock-wave-technology-for-the-therapy-of-diabetic-foot-ulcer/Healthcare in Germany is quite good. Pharmaceutical and biotechnology companies carry out research in order to improve it further. The question is, how can a fair price for innovative drugs be determined? BIOPRO Baden-Württemberg GmbH has talked to Dr. Manfred Caeser, a specialist in pricing and reimbursement at LSCN Ltd.
https://www.gesundheitsindustrie-bw.de/en/article/news/expert-interview-how-are-the-prices-of-new-pharmaceuticals-determined/A trade fair turns 20 and an industrial sector is coming of age. Where does BIO stand today? The number of exhibitors has slightly decreased the conference is characterised by general themes and trends and partnering has become the most important and indispensable part of the global event for biotechnology. What was once a gold rush atmosphere has given way to an experienced self-confidence about the economic importance of biotechnology.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/impressions-from-the-2013-bio-international-convention-in-chicago/Quantum biology has the potential to become the next big research coup. Professor Martin Plenio, 46, director of the Institute of Theoretical Physics at Ulm University and one of the world’s leading quantum technologists, is right at the forefront. He has been Alexander von Humboldt Professor since 2009, and holds a part-time professorship at Imperial College London, where he was formerly chair of quantum physics.
https://www.gesundheitsindustrie-bw.de/en/article/news/martin-plenio-turning-ulm-s-quantum-biology-into-a-technology-forge/The five university hospitals in Baden-Württemberg are aiming to pool their expertise on rare diseases in order to be able to improve and speed up patient treatment. The first Treatment and Research Centre for Rare Diseases (ZSE) was established in Germany in January 2010, and the first coordination workshop was held in July 2010. At the July meeting in Tübingen and a subsequent meeting held at the University of Freiburg, the partners discussed their common goals.
https://www.gesundheitsindustrie-bw.de/en/article/news/network-for-rare-diseases-in-baden-wuerttemberg/Although standing upright and moving forward may appear to be simple, they are in fact complex activities that are not yet understood in detail. Even less is known about how we hop, run and jump. Researchers at the Stuttgart-based Institute of Sport and Movement Science are looking into the ways the musculoskeletal system interacts to create movements as well as studying the effect of disorders. Computer simulation is one of the principal tools being used by the researchers to investigate human motion.
https://www.gesundheitsindustrie-bw.de/en/article/news/sounding-out-human-motion/Scientists at the BioQuant centre in Heidelberg have developed an automatic particle tracking method that can be used for time-resolved two- and three-dimensional microscope image data. This powerful computational method achieved the best overall result in an international competition that compared different methods for the quantitative tracking of the position of moving biological particles.
https://www.gesundheitsindustrie-bw.de/en/article/news/automatic-tracking-of-biological-particles/Harvest time has now come for physicist Alwin Kienle. In the next year or two the results of his basic research will result in the establishment of an applied centre focusing on the determination of the optical characteristics of scattering media. The deputy director of the Ulm-based ILM hopes that the new optical competence centre will lead to attractive solutions for the pharmaceutical medical device and nutrition sectors.
https://www.gesundheitsindustrie-bw.de/en/article/news/alwin-kienle-an-eye-for-the-whole-picture/The first and so far only clinical DFG research group on urology is being coordinated by a team from Tübingen. The team is developing a cell-based therapy for the regeneration of the urethral sphincter. Clinicians, life scientists and engineers are working together to try and find a causal therapy of stress incontinence.
https://www.gesundheitsindustrie-bw.de/en/article/news/large-scale-urology-project-cell-therapy-for-the-treatment-of-stress-incontinence/It’s not computer science, but it’s close to data: Prof. Dr. Peter Martus has an in-depth knowledge of how professional biotechnology and medical statistics are generated. Prof. Martus works at the University of Tübingen where he brings his know-how to clinical trials as well as working on life sciences projects where statistical issues need to be resolved.
https://www.gesundheitsindustrie-bw.de/en/article/news/biometry-peter-martus-works-at-the-interface-of-mathematics-and-medicine/The strategic alliance between the cell and tumour biology research priority at the German Cancer Research Center and the Center for Molecular Biology at Universität Heidelberg has led to the development of one of the largest centres of basic biomedical research in Germany. The top international profile of this interdisciplinary institution located at the interface between molecular and cellular biology tumour biology and biomedicine is reflected in the high-calibre speakers who will give presentations at the DKFZ-ZMBH Alliance Forum on Aging Cancer to be held in Heidelberg between 19th and 21st May 2011.
https://www.gesundheitsindustrie-bw.de/en/article/news/the-dkfz-zmbh-alliance/IBR Inc. a science-based provider of preclinical and clinical services specialises in inflammatory diseases. The analyses it carries out for the pharmaceutical and biotech sector help exclude potential side effects of specific drug candidates early in the development process.
https://www.gesundheitsindustrie-bw.de/en/article/news/ibr-inc-dual-strategy-for-safe-and-effective-drugs/Prof. Dr. Christian Bonten has been head of the Institute for Polymer Technology IKT at the University of Stuttgart since 1st September 2010. The former Institute for Plastics Testing and Science has recently become part of the IKT and has therefore come under Bontens area of responsibility. Bonton believes that bioplastics have great future potential and he plans to set milestones to drive bioplastics development forward.
https://www.gesundheitsindustrie-bw.de/en/article/news/christian-bonten-focuses-mainly-on-bioplastics/Karl Stock takes abstract ideas and turns them into useable technological possibilities. The 44-year-old works in what could best be described as the one-man engineering office at the Ulm-based Institute of Laser Technologies in Medicine and Metrology (ILM). In contrast to university institutes, Stock’s work does not simply finish with a “paper” published in a journal. Stock strives to go further and his real work starts where others often stop, and this extra work may well lead to a functional model or prototype.
https://www.gesundheitsindustrie-bw.de/en/article/news/karl-stock-helps-turn-ideas-into-products/Dietmar Hopp entrepreneur and co-founder of SAP sports patron biotech investor provider of funds and great promoter of his native region has turned 70. To celebrate the occasion the German Federal President has awarded Hopp the Great Cross of Merit of the Federal Republic of Germany Bundesverdienstkreuz which was presented to him by the Baden-Württemberg Minister President Stefan Mappus.
https://www.gesundheitsindustrie-bw.de/en/article/news/dietmar-hopp-awarded-great-cross-of-merit-on-his-70th-birthday/After a traumatic experience, people often suffer not only mental, but also physical effects. Dr. María Moreno-Villanueva from the University of Konstanz has investigated the molecular effects of traumatic stress in people and has found a higher than normal number of DNA strand breaks. In the worst cases this can lead to diseases such as cancer. However, her study also shows that successful psychotherapy can reverse DNA damage. Her findings will contribute to the development of new methods for the diagnosis and therapy of traumatic stress disorders.
https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-effects-of-traumatic-stress/Teleradiology is the most advanced telemedicine application in Germany. CHILI GmbH from Dossenheim is one of the companies that has contributed to driving the development of teleradiology forward. The company specialises in PACS and teleradiology systems and helps connect clinics and physicians.
https://www.gesundheitsindustrie-bw.de/en/article/news/chili-gmbh-teleradiology-pioneers/Prof. Heiko Möller is head of the NMR Core Facility a centre at the University of Constance that focuses on magnetic resonance spectroscopy where fingerprints of molecules are taken. The highly sensitive analysis instruments are used by his group of researchers for research projects on subjects ranging from severed visual nerves cancer protection and the rapid identification of anthrax bacteria.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-fingerprints-of-molecules/EHRs, i.e. electronic health records (German: Patientenakte, ePA), are hailed as the key to increasing the quality of care. The Appointment Service and Supply Act (TSVG), adopted on 14th March 2019, requires the German statutory health insurance funds to provide policyholders with electronic health records from 1st January 2021 onwards.
https://www.gesundheitsindustrie-bw.de/en/article/news/ehr-and-phr-digital-records-in-the-german-healthcare-system/
